A very low toxic agent induces apoptosis and reduces growth of human hepatocellular carcinoma cells

Journal of Gastroenterology and Hepatology (Australia)

Volumn 21, Issue 7, 2006, Pages 1207-1212

  Schumacher, Guido ^a   Scheunert, Sylvia ^a   Rueggeberg, Anne ^a   Bachem, Max G ^b   Nussler, Andreas K ^a   Spinelli, Antonino ^a   Mukhopadhyay, Tapas ^c,d   Pratschke, Johann ^a   Neuhaus, Peter ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b UNIVERSITY OF ULM   (Germany)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d PANJAB UNIVERSITY   (India)

Author keywords

2 methoxyestradiol; Apoptosis; Hep3B; Hepatocellular carcinoma; Hepatocytes; PLC PRF 5; SK Hep1

Indexed keywords

2 METHOXYESTRADIOL; ANTINEOPLASTIC AGENT; PROTEIN P21; PROTEIN P53;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CARCINOMA CELL; CELL COUNT; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; LIVER CELL; LIVER CELL CARCINOMA; PRIORITY JOURNAL;

EID: 33646236421     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2006.04327.x     Document Type: Article

References (29)

1. Merriam GR MacLusky NJ Picard MK Naftolin F. Comparative properties of the catechol estrogens, I: methylation by catechol-O-methyltransferase and binding to cytosol estrogen receptors. Steroids 1980 36 : 1 11.
2. LaVallee TM Zhan XH Herbstritt CJ Kough EC Green SJ Pribluda VS. 2-Methoxyestradiol inhibits proliferation and induces apoptosis independently of estrogen receptors alpha and beta. Cancer Res. 2002 62 : 3691 7.
3. Klauber N Parangi S Flynn E Hamel E D'Amato RJ. Inhibition of angiogenesis and breast cancer in mice by the microtubule inhibitors 2-methoxyestradiol and taxol. Cancer Res. 1997 57 : 81 6.
4. Mukhopadhyay T Roth JA. Superinduction of wild-type p53 protein after 2-methoxyestradiol treatment of Ad5p53-transduced cells induces tumor cell apoptosis. Oncogene 1998 17 : 241 6.
5. Kataoka M Schumacher G Cristiano RJ Atkinson EN Roth JA Mukhopadhyay T. An agent that increases tumor suppressor transgene product coupled with systemic transgene delivery inhibits growth of metastatic lung cancer in vivo. Cancer Res. 1998 58 : 4761 5.
6. Schumacher G Kataoka M Roth JA Mukhopadhyay T. Potent antitumor activity of 2-methoxyestradiol in human pancreatic cancer cell lines. Clin. Cancer Res. 1999 5 : 493 9.
7. Wassberg E. Angiostatic treatment of neuroblastoma. Ups. J. Med. Sci. 1999 104 : 1 24.
8. Lin HL Liu TY Chau GY Lui WY Chi CW. Comparison of 2-methoxyestradiol- induced, docetaxel-induced, and paclitaxel-induced apoptosis in hepatoma cells and its correlation with reactive oxygen species. Cancer 2000 89 : 983 94.
9. Bu S Blaukat A Fu X Heldin NE Landstrom M. Mechanisms for 2-methoxyestradiol-induced apoptosis of prostate cancer cells. FEBS Lett. 2002 531 : 141 51.
10. Arbiser JL Panigrathy D Klauber N et al. The antiangiogenic agents TNP-470 and 2-methoxyestradiol inhibit the growth of angiosarcoma in mice. J. Am. Acad. Dermatol. 1999 40 : 925 9.
11. Reiser F Way D Bernas M Witte M Witte C. Inhibition of normal and experimental angiotumor endothelial cell proliferation and cell cycle progression by 2-methoxyestradiol. Proc. Soc. Exp. Biol. Med. 1998 219 : 211 16.
12. Fotsis T Zhang Y Pepper MS et al. The endogenous oestrogen metabolite 2-methoxyestradiol inhibits angiogenesis and suppresses tumor growth. Nature 1994 368 : 237 9.
13. Gao N Rahmani M Dent P Grant S. 2-Methoxyestradiol-induced apoptosis in human leukemia cells proceeds through a reactive oxygen species and Akt-dependent process. Oncogene 2005 14 : 3797 809.
14. Strom SC Dorko K Thompson MT et al. Large scale isolation and culture of human hepatocytes. In : Franco D Boudjema K Varet B, eds. Ilots de Langerhans et Hépatocytes, Vol. 1. Geneva : Les Editions Inserm, 1993 195 205.
15. Hamada K Alemany R Zhang WW et al. Adenovirus-mediated transfer of a wild-type p53 gene and induction of apoptosis in cervical cancer. Cancer Res. 1996 56 : 3047 54.
16. Bachem MG Wendelin D Schneiderhan W et al. Depending on its concentration oxidized low density lipoproteins stimulate extracellular matrix synthesis or induce apoptosis in human coronary artery smooth muscle cells. Clin. Chem. Lab. Med. 1999 37 : 319 26.
17. Weber AK Wahn U Renz H. Superantigen-induced T cell death by apoptosis: analysis on a single cell level and effect of IFN-γ and IL-4 treatment. Int. Arch. Allergy Immunol. 2000 121 : 215 23.
18. Mukhopadhyay T Roth JA. Induction of apoptosis in human lung cancer cells after wild-type p53 activation by methoxyestradiol. Oncogene 1997 14 : 379 84.
19. Nakagawa-Yagi Y Ogane N Inoki Y Kitoh N. The endogenous estrogen metabolite 2-methoxyestradiol induces apoptotic neuronal cell death in vitro. Life Sci. 1996 58 : 1461 7.
20. Lin HL Liu TY Wu CW Chi CW. 2-Methoxyestradiol-induced caspase-3 activation and apoptosis occurs through G (2) /M arrest dependent and independent pathways in gastric carcinoma cells. Cancer 2001 92 : 500 9.
21. Zhu BT Conney AH. Is 2-methoxyestradiol an endogenous estrogen metabolite that inhibits mammary carcinogenesis? Cancer Res. 1998 58 : 2269 77.
22. Tsukamoto A Kaneko Y Yoshida T Han K Ichinose M Kimura S. 2-Methoxyestradiol, an endogenous metabolite of estrogen, enhances apoptosis and beta-galactosidase expression in vascular endothelial cells. Biochem. Biophys. Res. Commun. 1998 248 : 9 12.
23. Yue TL Wang X Louden CS et al. 2-Methoxyestradiol, an endogenous estrogen metabolite, induces apoptosis in endothelial cells and inhibits angiogenesis: possible role for stress-activated protein kinase signaling pathway and Fas expression. Mol. Pharmacol. 1997 51 : 951 62.
24. D'Amato RJ Lin CM Flynn E Folkman J Hamel E. 2-Methoxyestradiol, an endogenous mammalian metabolite, inhibits tubulin polymerization by interacting at the colchicine site. Proc. Natl Acad. Sci. USA 1994 91 : 3964 8.
25. Attalla H Mäkelä TP Adlercreutz H Andersson LC. 2-Methoxyestradiol arrests cells in mitosis without depolymerizing tubulin. Biochem. Biophys. Res. Commun. 1996 228 : 467 73.
26. McCormick DL Johnson WD Pribluda VS Green SJ Tomaszewski JE Smith AC. Preclinical development of 2-methoxyestradiol (2ME2, NSC-659853). [Abstract]. Proc. Am. Assoc. Cancer Res. 2000 41 : 328.
27. Seegers JC Lottering ML Grobler CJ et al. The mammalian metabolite, 2-methoxyestradiol, affects P53 levels and apoptosis induction in transformed cells but not in normal cells. J. Steroid Biochem. Mol. Biol. 1997 62 : 253 67.
28. Huang P Feng L Oldham EA Keating MJ Plunkett W. Superoxide dismutase as a target for the selective killing of cancer cells. Nature 2000 407 : 390 5.
29. Tsutsui T Tamura Y Hagiwara M et al. Induction of mammalian cell transformation and genotoxicity by 2-methoxyestradiol, an endogenous metabolite of estrogen. Carcinogenesis 2000 21 : 735 40.